Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
12/22/2004 | CN1181092C Conjugates useful in treatment of prostate cancer |
12/22/2004 | CN1181091C Factor Xa inhibitors |
12/22/2004 | CN1181090C Aspartyl dipeptide ester derivatives and sweeteners |
12/22/2004 | CN1181069C Novel inhibitors of farnesyl-protein transferase |
12/21/2004 | US6833448 Annexin derivatives with endogenous chelation sites |
12/16/2004 | WO2004108938A2 Peptide ligands of dendritic cells for nucleic acid vector targeting |
12/16/2004 | WO2004108070A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
12/16/2004 | US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
12/16/2004 | US20040254343 Crystals of N2-(N,N-dimethyl-L-valyl)-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide with potent antitumor activity |
12/16/2004 | US20040254342 Substrates and assays for beta-secretase |
12/16/2004 | US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors |
12/16/2004 | US20040254339 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |
12/16/2004 | US20040254226 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents |
12/16/2004 | US20040254225 Modulation of opioid receptor by binding |
12/16/2004 | US20040254167 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
12/16/2004 | US20040254120 Stimulating high density lipoproteins; osteoporosis; detoxification |
12/16/2004 | US20040254117 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
12/16/2004 | US20040254114 Genetic engineering |
12/16/2004 | US20040254110 Methods for diagnosing and treating Alzheimer's disease |
12/16/2004 | US20040253706 Substrates and assays for beta-secretase |
12/16/2004 | US20040253687 Using multicompartment apparatus and affinity chromatography to isolate/purify preferential protein from cell solutions |
12/16/2004 | US20040253682 Immunloglobulin prostaglandin inhibitor for use in the treatment and prevention of arthritic and inflammatory bowel disorders |
12/16/2004 | US20040253665 Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them |
12/16/2004 | US20040250751 Crystals of oxidized glutathione and process for producing the same |
12/16/2004 | CA2526482A1 Peptide ligands of dendritic cells for nucleic acid vector targeting |
12/16/2004 | CA2526007A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
12/15/2004 | EP1486206A1 New uses for amino acid anticonvulsants for treatment of bipolare disorder |
12/15/2004 | EP1486205A1 New uses for amino acid anticonvulsants for treatment of migraine |
12/15/2004 | EP1485406A2 Highly homogeneous molecular markers for electrophoresis |
12/15/2004 | EP1485346A1 Novel positively charged lipids and liposomes comprising the positively charged lipids |
12/15/2004 | EP1485345A2 Urokinase inhibitors, production and use thereof |
12/15/2004 | EP1485115A2 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers |
12/15/2004 | EP1485107A1 Phospholipids as caspase inhibitor prodrugs |
12/15/2004 | EP1421204A4 Iap binding peptides and assays for identifying compounds that bind iap |
12/15/2004 | EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals |
12/15/2004 | EP1226160B1 Novel antiarrhythmic peptides |
12/15/2004 | CN1555372A Pyrane derivatives as both ace- and nep- inhibitors |
12/15/2004 | CN1179972C Growth hormone secretagogues |
12/14/2004 | US6831199 Pyrimidine compounds and derivatives thereof |
12/14/2004 | US6831196 Such as benzylsulfonyl-D-Ser-Gly-4-amidinobenzylamide, HCl salt; for treatment of malign tumors/metastatic spread |
12/14/2004 | US6831099 Enzyme inhibition |
12/14/2004 | US6831066 Amyloid precursor proteins with improved bioavailability; for treament of Alzheimer's disease |
12/14/2004 | US6831061 Apicidin-derivatives, their synthetic methods and anti-tumor compositions containing them |
12/14/2004 | US6830894 Compounds and methods for modulating claudin-mediated functions |
12/11/2004 | CA2431560A1 Derivatives of streptogramins, their preparation and compositions containing them |
12/09/2004 | WO2004106364A1 Stabilizing peptides and their use in the preparation of stabilized hiv inhibitors |
12/09/2004 | WO2004106289A1 Protease inhibitors |
12/09/2004 | WO2004092203A3 Process for preparing macrocyclic compounds |
12/09/2004 | WO2004028473A3 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
12/09/2004 | WO2004006866A3 Antifungal therapeutic targets |
12/09/2004 | US20040249187 Method for producing chiral amino acid derivatives |
12/09/2004 | US20040248894 Controlling blood ingesting, disease spreading pests; biodegradable; nontoxic to humans and animals |
12/09/2004 | US20040248817 Therapy for cardiovascular disorders; hypotensive agents; congestive heart failure |
12/09/2004 | US20040248814 does not require the problematic use of protecting groups |
12/09/2004 | US20040248808 Methods for preventing mitochondrial permeability transition |
12/09/2004 | US20040248783 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
12/09/2004 | US20040248779 subjecting a diene to metathesis cyclization reaction in the presence of a benzylidene ruthenium catalyst |
12/09/2004 | US20040248212 determine the specific sequence of that portion of peptides or proteins that bind to a receptor or target of interest, or mediate a biological activity of interest; forming a metallopeptides with serially substituted sequences and screening for altered binding activity; metallopeptide libraries |
12/09/2004 | US20040248198 Arf and hdm2 interaction domains and methods of use thereof |
12/09/2004 | US20040247523 Diagnosing and localizing sites of inflammation and perfusion abnormalities (e.g. reperfusion injury, vulnerable plaque, bacterial endocarditis or cardiac transplant rejection) in a single dual isotope imaging procedure, particularly CT imaging, ultrasound, or scintigraphy. |
12/08/2004 | EP1483290A2 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
12/08/2004 | EP1483285A1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME |
12/08/2004 | EP1483284A2 Selective dipeptide inhibitors of kallikrein |
12/08/2004 | EP1482960A2 Methods and products for oral care |
12/08/2004 | EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
12/08/2004 | EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
12/08/2004 | EP1045858B1 Anti-cryptococcal peptides |
12/08/2004 | EP0934951B1 Plant cell growth factors |
12/08/2004 | CN1553897A Dolastatin 10 derivatives |
12/08/2004 | CN1553892A Novel compounds and compositions as cathepsin inhibitors |
12/08/2004 | CN1552894A Corn peptide and its preparation and use |
12/08/2004 | CN1552737A Process for the preparation of resin-bound cyclic peptides |
12/08/2004 | CN1178954C Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
12/08/2004 | CN1178953C Synthesis and recovery of aspartame involving enzymatic deformylation step |
12/08/2004 | CN1178912C Small molecule inhibitors of rotamase enzyme activity |
12/08/2004 | CN1178905C Novel peptide derivative |
12/07/2004 | US6828343 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
12/07/2004 | US6828331 Growth hormone secretagogues |
12/07/2004 | US6828302 Therapeutic uses of depsipeptides and congeners thereof |
12/02/2004 | WO2004104031A2 Modified antiviral peptides with increased activity and cell membrane affinity |
12/02/2004 | WO2004104027A1 Composition containing angiotensin converting enzyme inhibitory peptide |
12/02/2004 | WO2004104026A1 Peptide complex |
12/02/2004 | WO2004103996A1 Hepatitis c inhibitor compounds |
12/02/2004 | WO2004103993A1 Dipeptidyl peptidase inhibitors |
12/02/2004 | WO2004103984A1 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
12/02/2004 | WO2004103969A1 Novel method for the synthesis of (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof, and application in the synethesis of perindopril |
12/02/2004 | WO2004103389A2 Means for preventing and treating cellular death and their biological applications |
12/02/2004 | WO2004103270A2 Compounds and methods for treatment of thrombosis |
12/02/2004 | WO2004060916A3 Peptide compound containing boron |
12/02/2004 | WO2004060264A3 Metastin derivatives and their use |
12/02/2004 | US20040242606 Anti-cancer cyclopenta (g)quinazoline compounds |
12/02/2004 | US20040242491 For use in the treatment of gout and related symptoms or in the amelioration of symptoms related to a high level of uric acid such as muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, or as a dietary supplement |
12/02/2004 | US20040241792 Substrates and assays for beta-secretase |
12/02/2004 | US20040241791 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
12/02/2004 | US20040241731 Methods of producing nucleic acid ligands |
12/02/2004 | US20040241664 Protein Hydrolysates Enriched In Peptides Having A Carboxy Terminal Proline Residue |
12/02/2004 | US20040241096 Detect enzyme activity in sample; incubation target tissue; detect amplification in sample |
12/02/2004 | CA2526493A1 Means for preventing and treating cellular death and their biological applications |
12/02/2004 | CA2526069A1 Modified antiviral peptides with increased activity and cell membrane affinity |
12/01/2004 | EP1481078A2 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |